This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.
David ArmstrongSackler family statement also deceptively attempts to minimize impact of OxyContin by saying it was “tiny portion” of opioid market and never more than 4% of prescriptions nationally
As OxyContin addiction spurred a national nightmare, a member of the family that has reaped billions of dollars from the painkiller boasted that sales exceeded his “fondest dreams,” according to a secret court document obtained by ProPublica.
David ArmstrongWe have published the deposition of Richard Sackler that OxyContin maker Purdue Pharma has fought to keep secret for three years
The insurance industry gives lucrative commissions and bonuses — from six-figure payouts to a chance to bat against Mariano Rivera — to the independent brokers who advise employers. Critics call the payments a “classic conflict of interest” that...
David ArmstrongFor anyone paying premiums on private health insurance, this story from @marshall_allen on the upside down world of insurance brokers is a must read
Secret portions of a lawsuit allege that Purdue Pharma, controlled by the Sackler family, considered capitalizing on the addiction treatment boom — while going to extreme lengths to boost sales of its controversial opioid.
David ArmstrongHere is what OxyContin maker Purdue Pharma did not want you to read
The deposition of Richard Sackler is believed to be the only time a member of the family that owns Purdue has been questioned under oath about OxyContin.
David ArmstrongCongress seeks copy of deposition of Richard Sackler, a member of the family that owns Oxycontin maker Purdue Pharma. What is taking Kentucky court of appeals so long to rule on @statnews case to unseal same document?
David ArmstrongIn 2016, a Kentucky judge approved a @statnews motion to unseal the depsition of Richard Sackler, a member of the family that owns OxyContin maker Purdue Pharma. Company appealed and KY appeals court said it would rule by last fall. Still no ruling.
As ProPublica updates Dollars for Docs, we found that drugmakers spent less money to market opioids to doctors in 2016 than in prior years. Studies have shown that payments to doctors by opioid makers are linked to more prescribing of the drugs.
David ArmstrongAs lawsuits and scrutiny mount, payments to doctors from makers of opioid painkillers fall
OxyContin maker Purdue Pharma laid off about 350 employees this week, with about half of them making up the remainder of the company's already-downsized sales force, Hearst Connecticut Media has learned.
About 90 Stamford-based positions were cut,...
David ArmstrongEnd of an era for OxyContin maker Purdue Pharma. After netting billions in profits from the aggressive marketing of the opioid painkiller, company shuts down sales force and lays off 350
The annual event — called the Party At BIO Not Associated With BIO, or PABNAB for short — has a reputation for bringing over-the-top themes and festivities to an industry networking event. Not everyone was impressed.
Over decades, Bud Frazier has played a leading role in the development of mechanical heart pumps and an artificial heart. Out of public view, he’s been accused of putting his quest to make history ahead of the needs of some patients.
David ArmstrongThe conflicts of a surgeon/researcher, and the impact on heart patients and the bottom line of the hospital where the procedures were performed. The latest in a series from @charlesornstein